Desiree Ratner, MD Email Desiree Ratner
- CLINICAL PROFESSOR | Dermatology
- Hospital Affiliations
- Mount Sinai St. Luke's and Mount Sinai West
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
Desiree Ratner, MD, is Director of the Comprehensive Skin Cancer Center at the Mount Sinai Beth Israel Medical Center, Director of Dermatologic Surgery at Mount Sinai Beth Israel and Mount Sinai West, and Professor of Dermatology at the Icahn School of Medicine. She specializes in Mohs micrographic surgery, cutaneous oncology, and facial reconstruction. Dr. Ratner did her medical training at the Johns Hopkins University School of Medicine. She did her internship in internal medicine at Beth Israel Hospital in Boston, followed by her dermatology residency at the University of Michigan Medical Center in Ann Arbor. She then did two years of fellowship training in Mohs micrographic surgery, reconstruction, and general dermatologic surgery with Dr. Donald Grande, first at New England Medical Center in Boston, MA, and then at the Lahey Clinic in Burlington MA. After practicing in Baltimore and teaching part time in the Departments of Dermatology at Johns Hopkins and the University of Maryland affiliated Veterans Administration Hospital, she returned to New York City and became the Director of Dermatologic Surgery at Columbia University Medical Center of the New York Presbyterian Hospital, where she remained from 1997 to 2012.
Dr. Ratner has served on the Boards of Directors of the American College of Mohs Surgery, the International Transplant Skin Cancer Collaborative Group, and the Association of Academic Dermatologic Surgeons. She has served as Chair of the Sulzberger Institute of the American Academy of Dermatology and is currently the Immediate Past Chair of the Procedural Dermatology section of the Association of Professors of Dermatology. She has been Co-Editor of the Dermatologic Surgery Journal since 2007, and is an Editorial Board member for the Journal of the American Academy of Dermatology. She has authored or coauthored more than 100 publications, and has given over 100 presentations at national and international meetings. She has been listed as one of the Castle Connelly Top Doctors since 2005, and as one of the New York Times Best Doctors and America’s Top Surgeons since 2009.
- Basal Cell Carcinoma
- Melanoma Removal
- Mohs Micrographic Surgery
- Mohs Surgery
- Skin Biopsy
- Skin Cancer
- Skin Lesion Removal
- Squamous Cell Carcinoma
Zilkha Foundation Scholarship, Institut de Recherches Scientifiques sur le Cancer
Doctor of Medicine, Johns Hopkins University School of Medicine
Bachelor of Arts, Brown University
Teacher of the Year
Department of Dermatology, Columbia University
Listed in New York Magazine's Best Doctors
New York Magazine
Listed in Super Doctors
New York TImes Magazine
Listed in Castle Connolly's Best Doctors
American Dermatological Association
Cumulative Resident Teaching Award
Department of Dermatology, Columbia University
Continuing Medical Education Award
American Academy of Dermatology
Continuing Medical Education Award
American Academy of Dermatology
Theodore Tromovitch Award
American Collefe of Mohs Micrographic Surgery and Cutaneous Oncology
Upjohn Research Award
University of Michigan Medical Cener
Phi Beta Kappa
Ratcliffe Hicks Prize for Debate
Naitonal Merit Finalist
Alam M, Shah AD, Ali S, Rauf M, Nodzenski M, Ibrahim O. Floaters in Mohs micrographic surgery. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2013 Sep; 39(9).
Henry M, O'Bryan K, Ratner D. Combination repair of a complex central facial defect using multiple flaps and grafts. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2013 Jul; 39(7).
Nelson AM, Ruiz ME, Ratner D, Jensen UB, Thieu K, Owens DM, Lumpkin EA. TRPV3 signaling arrests human keratinocyte proliferation and inhibits cutaneous squamous cell carcinoma. Journal of Clinical Investigation;.
Levender MM, Ratner D. Reconstructing complex central facial defects involving multiple cosmetic subunits. Facial plastic surgery : FPS 2013 Oct; 29(5).
Sambandan DR, Ratner D. Sunscreens: an overview and update. Journal of the American Academy of Dermatology 2011 Apr; 64(4).
Johnson-Jahangir H, Stevenson M, Ratner D. Modified flap design for symmetric reconstruction of the apical triangle of the upper lip. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2012 Jun; 38(6).
Muldoon TJ, Burgess SA, Chen BR, Ratner D, Hillman EM. Analysis of skin lesions using laminar optical tomography. Biomedical optics express 2012 Jul; 3(7).
Back JH, Rezvani HR, Zhu Y, Guyonnet-Duperat V, Athar M, Ratner D, Kim AL. Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1. The Journal of biological chemistry 2011 May; 286(21).
O'Bryan K, Sherman W, Niedt GW, Taback B, Manolidis S, Wang A, Ratner D. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology 2013 Oct; 69(4).
Johnson-Jahangir H, Ratner D. Advances in management of dermatofibrosarcoma protuberans. Dermatologic clinics 2011 Apr; 29(2).
Lee DA, Ratner D. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2006 Jul; 32(7).
Sambandan DR, Ratner D. Vascular complications after treatment with low-dose isotretinoin in two elderly patients. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2011 May; 37(5).
Miller K, Sherman W, Ratner D. Complete clinical response to cetuximab in a patient with metastatic cutaneous squamous cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2010 Dec; 36(12).
Johnson-Jahangir H, Sherman W, Ratner D. Using imatinib as neoadjuvant therapy in dermatofibrosarcoma protuberans: potential pluses and minuses. Journal of the National Comprehensive Cancer Network : JNCCN 2010 Aug; 8(8).
Halpern M, Adams C, Ratner D. Galeal hinge flaps: a useful technique for immediate repair of scalp defects extending to periosteum. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2009 Jan; 35(1).
Ibrahim SF, Sambandan D, Ratner D. Immunotherapy for cutaneous malignancy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2011 Oct; 37(10).
Han A, Chen EH, Niedt G, Sherman W, Ratner D. Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans. Archives of dermatology 2009 Jul; 145(7).
McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PloS one 2007; 2(12).
Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?. Cancer 2007 Mar; 109(6).
Kimmel Z, Ratner D, Kim JY, Wayne JD, Rademaker AW, Alam M. Peripheral excision margins for dermatofibrosarcoma protuberans: a meta-analysis of spatial data. Annals of surgical oncology 2007 Jul; 14(7).
Herman S, Rogers HD, Ratner D. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients. Skinmed; 6(5).
Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. The New England journal of medicine 2005 Nov; 353(21).
Adams C, Ratner D. Composite and free cartilage grafting. Dermatologic clinics 2005 Jan; 23(1).
Farley R, Manolidis S, Ratner D. Adenocarcinoma of the lung metastatic to the skull presenting as a scalp cyst. Journal of the American Academy of Dermatology 2006 May; 54(5).
Farley RL, Manolidis S, Ratner D. Aggressive basal cell carcinoma with invasion of the parotid gland, facial nerve, and temporal bone. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2006 Feb; 32(2).
Chung VQ, Bernardo L, Jiang SB. Presurgical curettage appropriately reduces the number of Mohs stages by better delineating the subclinical extensions of tumor margins. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2005 Sep; 31(9 Pt 1).
Zurada J, Ratner D. Diagnosis and treatment of basal cell nevus syndrome. Skinmed; 4(2).
Chen EH, Johnson TM, Ratner D. Introduction to flap movement: reconstruction of five similar nasal defects using different flaps. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2005 Aug; 31(8 Pt 2).
Geyer AS, Pasternack F, Adams C, Ratner D. Use of a skin-fat composite graft to prevent alar notching: an alternative to delayed postoperative repair. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2005 May; 31(5).
Ratner D. Commentary: new developments in cutaneous oncology. Clinics in dermatology; 22(3).
Delshad E, Ratner D. Microcystic adnexal carcinoma. Skinmed; 3(6).
Zwald FO, Christenson LJ, Billingsley EM, Zeitouni NC, Ratner D, Bordeaux J, Patel MJ, Brown MD, Proby CM, Euvrard S, Otley CC, Stasko T. Melanoma in solid organ transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010 May; 10(5).
Ratner D. Reflections on Mohs micrographic surgery. Skinmed; 3(4).
O'Bryan KW, Ratner D. The role of targeted molecular inhibitors in the management of advanced nonmelanoma skin cancer. Seminars in cutaneous medicine and surgery 2011 Mar; 30(1).
Ratner D. Introducing Practice-Gap Focused Commentaries in Dermatologic Surgery. Dermatol Surg 2012; 38(10): 1579-80.
O'Bryan KW, Sambadan D, Ratner D. Basal Cell Carinoma: Current Concepts and Future Directions. Practical Dermatol 2011;: 3-8.
Alam M, Kim NA, Harvey J, Rademaker A, Ratner D, Tregre B, West DP, Coleman WP. Blinded versus unblinded peer review of manuscripts submitted to a dermatology journal: a randomized muti-rater study. BJD 2011; 163(3): 563-7.
Halem ML, Ratner D, Patel A. Basal Cell Carcinoma. In: Evidence Based Procedural Dermatology. New York, Springer; 2010. pp33-56.
Ratner D, MacGregor J, Mohs J. Micrographic Surgery. In: MacFarlane D, editor. Skin Cancer Management. New York, Springer; pp143-52.
Mehta PS, Halpern ME, Ratner D, Harrison LB. Basal and squamous cell skin cancers. In: Head and Neck Cancer. Philadelphia, Lippincott Williams and Wilkins; pp544-60.
Ratner D, Eickhorst K. Leonard A. Aesthetic Procedure Guide. Scar Revision 2007;.
Ratner D. Dermatologic Surgery Made Easy: a review. J Derm Treatment 2007; 18(1): 63.
Rogers H, Chen EH, Ratner D. Transplant Lip: Severe Actinic Damage of the Lip in Organ Transplant Recipients. In: Otley C, Salasche SJ, Stasko S, editors. Skin Disease in Organ Transplantation. New York, Cambridge University Press; pp238-41.
Ratner D. Surgery of the Skin: A Review. J Am Acad Dermatol 2006; 54: 367-8.
Halpern M, Chen EH, Ratner D, Alam M. Sarcomas. In: Nouri K, editor. Skin Cancer. New York, McGraw-Hill; pp214-21.
Farley R, Ratner D. Diagnosis and management of atypical fibroxanthoma. Skin Med; 5(2): 83-6.
Ratner D, Johnson . Guest Editors, Introduction to Special Issue on Reconstruction. Dermatol Surg 2005; 31: 981.
Chen EH, Ratner D, Kaufman HL. New technologies for the early diagnosis of melanoma. The Skin Cancer Foundation Jounal 2005; XXII: 47-50.
Rubin AL, Ratner D, Khatri VP. Basal Cell Carcinoma. In: Clinical Scenarios in Surgical Oncology. Philadelphia, Lippincott Williams & Wilkins; pp330-4.
Ratner D, Pol-Rodriguez M, Khatri VP. Squamous Cell Carcinoma. In: Clinical Scenarios in Surgical Oncology. Philadelphia, Lippincot Williams & Wilkins; 2004. pp321-9.
Wanner M, Ratner D. Flaps and Grafts in Dermatologic Surgery. In: Skin Grafting. Elsevier;.
Ratner D, H, Harahap M. Free cartilage grafts in nasal alar reconstruction. In: Innovative Techniques in Skin Surgery. New York, Marcel Dekker; pp393-398.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Ratner during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.